复星医药,梦碎了!

飞鲸投研
04 Apr

医药融资,寒冬未尽!据统计,2024年国内医疗健康产业投融资额持续下滑,降至73亿美元,融资事件数量也减少至811起,均不足2021年高峰期的四分之一。当前,全球医疗创投策略发生明显转变,不再一味聚焦创新潜力,而是更青睐成熟且确定性高的项目。这一转变使得多家创新药企,陷入“融资断供”的生死竞速之中,保住现金流成了企业能否继续走下去的关键。即便是身为行业巨头的复星医药,也未能置身事外。仅在2024...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10